We are a clinical-stage biopharmaceutical company dedicated to revolutionizing the treatment of neurodegenerative diseases to restore and protect neuronal health and function. Our nanotherapeutics target cellular energy impairments that are common to many diseases.
Our platform focuses on revolutionizing the treatment of neurodegenerative diseases with potential first-in-class nanotherapeutics. This novel approach has allowed us to explore broad applications of our drugs across therapeutic areas.
We believe in applying innovations to therapeutic challenges that currently have no effective solutions. With the right mix of experience, expertise, and creativity, we are changing the landscape of clinical development.